Nuclear imaging was born 60 years ago and it is still central to the imaging and treatment of thyroid disease. It is common knowledge that radionuclide-based strategy and artificially modified molecular probes have been used extensively in the diagnosis and treatment of thyroid disease. For instances, radioactive iodine and 18F-fluoro-D-glucose (18F-FDG) are widely applied to diagnose thyroid cancer and to predict the prognosis. According to many recent surveys conducted, advances in molecular probes have stimulated the development of many novel tracers based on antibody, peptide and nanoparticle platforms. New molecular probes have high sensitivity and specificity, which will facilitate the personalized and precision treatment of thyroid disease. Notably, many research revealed that radiation had affects the body in multiple aspects including thyroid-gut axis. It needs to be brought to our attention. In addition, reducing radiation exposure, taking protective measures and attending to the psychosocial changes during nuclear imaging are of great importance.
Through this collection of articles, we intend to collect original research, reviews, mini-reviews and opinion pieces focusing on the latest advances in nuclide imaging and molecular probes concerning the thyroid, an evolving and promising field of medicine. Special emphasis will be placed on the potential effects of radionuclides on the body and minimizing the side effects of radionuclide applications. At the same time, the research topic is open to new ideas about new strategy for thyroid treatment. The research topic will deal with radionuclide related issues in a realistic way and reveal the true potential of thyroid nuclide imaging.
Topics of interest include, but are not limited to:
• Effects of radiation on the thyroid-gut axis;
• Recent advances in the immune microenvironment of nucleotide marker-related thyroid tumors;
• Emerging strategies for the management of thyroid disease with 131I;
• Exploration of novel biomarkers of thyroid disease;
• Exploration of novel screening techniques and materials for the thyroid gland;
• Advances in research related to radioiodine tolerance mechanisms in thyroid cancer;
• Recent advances in thyroid nuclide imaging studies;
• Construction of animal models of thyroid disease and recent advances;
• Novel techniques for the diagnosis and treatment of 18F-FDG in thyroid lymph node or distant organ metastases;
• Radiation protection in nuclear medicine and related psychiatric disorders;
• Mechanisms of research progress in other complications of thyroidectomy;
• Nuclear therapy for prostate cancer.
Nuclear imaging was born 60 years ago and it is still central to the imaging and treatment of thyroid disease. It is common knowledge that radionuclide-based strategy and artificially modified molecular probes have been used extensively in the diagnosis and treatment of thyroid disease. For instances, radioactive iodine and 18F-fluoro-D-glucose (18F-FDG) are widely applied to diagnose thyroid cancer and to predict the prognosis. According to many recent surveys conducted, advances in molecular probes have stimulated the development of many novel tracers based on antibody, peptide and nanoparticle platforms. New molecular probes have high sensitivity and specificity, which will facilitate the personalized and precision treatment of thyroid disease. Notably, many research revealed that radiation had affects the body in multiple aspects including thyroid-gut axis. It needs to be brought to our attention. In addition, reducing radiation exposure, taking protective measures and attending to the psychosocial changes during nuclear imaging are of great importance.
Through this collection of articles, we intend to collect original research, reviews, mini-reviews and opinion pieces focusing on the latest advances in nuclide imaging and molecular probes concerning the thyroid, an evolving and promising field of medicine. Special emphasis will be placed on the potential effects of radionuclides on the body and minimizing the side effects of radionuclide applications. At the same time, the research topic is open to new ideas about new strategy for thyroid treatment. The research topic will deal with radionuclide related issues in a realistic way and reveal the true potential of thyroid nuclide imaging.
Topics of interest include, but are not limited to:
• Effects of radiation on the thyroid-gut axis;
• Recent advances in the immune microenvironment of nucleotide marker-related thyroid tumors;
• Emerging strategies for the management of thyroid disease with 131I;
• Exploration of novel biomarkers of thyroid disease;
• Exploration of novel screening techniques and materials for the thyroid gland;
• Advances in research related to radioiodine tolerance mechanisms in thyroid cancer;
• Recent advances in thyroid nuclide imaging studies;
• Construction of animal models of thyroid disease and recent advances;
• Novel techniques for the diagnosis and treatment of 18F-FDG in thyroid lymph node or distant organ metastases;
• Radiation protection in nuclear medicine and related psychiatric disorders;
• Mechanisms of research progress in other complications of thyroidectomy;
• Nuclear therapy for prostate cancer.